Bharat Biotech

The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.

New Delhi: Bharat Biotech, which has a stockpile of more than 50 million doses of Covaxin ready to be distributed as required, is well-tolerated and immunogenic in the paediatric population…

Hyderabad: The World Health Organization (WHO) is a step closer to granting an emergency use listing (EUL) to Covaxin after Bharat Biotech provided additional data on the vaccine sought by…

Bhubaneswar: Odisha on Tuesday received 1,11,100 doses of state-procured Covaxin vaccine. The consignment reached Bhubaneswar in a special flight. The vaccine manufactured by Bharat…

New Delhi: The supply price of COVID-19 vaccine Covaxin to the Central government at Rs 150 per dose is not sustainable in the long run, Bharat Biotech said on Tuesday. The Centre’s…

Patna: Bharat Biotech has started paediatric trials of its COVID-19 vaccine Covaxin at the All India Institute of Medical Sciences (AIIMS) Patna. The Drugs Controller General of India…

New Delhi: The Delhi High Court on Wednesday heard a PIL, to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech for conducting the phase II/III…

New Delhi: COVID-19 vaccine manufacturers Bharat Biotech and Serum Institute of India (SII) will get Rs 1,500 crore and Rs 3,000 crore each as supply credit from the Finance Ministry. The…

Bhubaneswar: All frontline workers will be vaccinated at their respective workplace, said Director, Health and Family Welfare Bijay Panigrahi here on Wednesday. The vaccination of…

New Delhi: Bharat Biotech's Covaxin is effective against the UK variant of the virus.  Taking to Twitter, Bharat Biotech said "Covaxin effectively neutralises UK variants of SARS-CoV-2…